Viewing Study NCT00086112


Ignite Creation Date: 2025-12-26 @ 10:43 PM
Ignite Modification Date: 2025-12-26 @ 10:43 PM
Study NCT ID: NCT00086112
Status: COMPLETED
Last Update Posted: 2012-07-23
First Post: 2004-06-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: None
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2005-06
Completion Date Type: ACTUAL
First Submit Date: 2004-06-24
First Submit QC Date: None
Study First Post Date: 2004-06-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2012-07-19
Last Update Post Date: 2012-07-23
Last Update Post Date Type: ESTIMATED